The store will not work correctly when cookies are disabled.
Ammonium 2-hydroxy-5-{5-[N-(p-nitrophenyl)aminomethyl]-2-furyl}benzoate
ID: ALA5197026
Chembl Id: CHEMBL5197026
PubChem CID: 168286365
Max Phase: Preclinical
Molecular Formula: C18H17N3O6
Molecular Weight: 354.32
Associated Items:
Names and Identifiers
Canonical SMILES: N.O=C(O)c1cc(-c2ccc(CNc3ccc([N+](=O)[O-])cc3)o2)ccc1O
Standard InChI: InChI=1S/C18H14N2O6.H3N/c21-16-7-1-11(9-15(16)18(22)23)17-8-6-14(26-17)10-19-12-2-4-13(5-3-12)20(24)25;/h1-9,19,21H,10H2,(H,22,23);1H3
Standard InChI Key: YFSGOSUWBFFDMS-UHFFFAOYSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 354.32 | Molecular Weight (Monoisotopic): 354.0852 | AlogP: 3.87 | #Rotatable Bonds: 6 |
Polar Surface Area: 125.84 | Molecular Species: ACID | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 2.66 | CX Basic pKa: 0.86 | CX LogP: 3.62 | CX LogD: 0.24 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.45 | Np Likeness Score: -0.99 |
References
1. Moya-Garzon MD, Rodriguez-Rodriguez B, Martin-Higueras C, Franco-Montalban F, Fernandes MX, Gomez-Vidal JA, Pey AL, Salido E, Diaz-Gavilan M.. (2022) New salicylic acid derivatives, double inhibitors of glycolate oxidase and lactate dehydrogenase, as effective agents decreasing oxalate production., 237 [PMID:35500475] [10.1016/j.ejmech.2022.114396] |